NCT03541733 is a NA clinical trial of mid-gut tubing in Crohn Disease, sponsored by The Second Hospital of Nanjing Medical University.

Who is sponsoring NCT03541733?

NCT03541733 is sponsored by The Second Hospital of Nanjing Medical University.

What drugs are being tested in NCT03541733?

Interventions in NCT03541733: mid-gut tubing.

What condition does NCT03541733 study?

NCT03541733 studies Crohn Disease.

Is NCT03541733 still recruiting?

NCT03541733 is currently completed. Last updated 4 April 2023.

Last reviewed 2023-04-04 · How we verify

NCT03541733

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bowel Preparation for Magnetic Resonance Enterography

Completed NA Last updated 4 April 2023

What this trial tests

NA trial testing mid-gut tubing in Crohn Disease in 102 participants. Completed in 28 February 2023.

Timeline

1 June 2018

Primary endpoint
28 February 2023

28 February 2023

Quick facts

Lead sponsor	The Second Hospital of Nanjing Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	102
Start date	1 June 2018
Primary completion	28 February 2023
Estimated completion	28 February 2023
Sites	1 location across China

Drugs / interventions tested

mid-gut tubing

Conditions studied

Crohn Disease — all drugs for Crohn Disease →

Sponsor

The Second Hospital of Nanjing Medical University

Who can join

14 and older, any sex, with Crohn Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adequate bowel preparation is required for magnetic resonance enterography (MRE) which can be achieved by two methods including administering contrast solution after mid-gut tubing and taking contrast solution orally. We present the design of randomized controlled trial to compare the efficacy and compliance of bowel preparation through mid-gut tubing with taking contrast orally for MRE in patients with Crohn's disease (CD).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The bowel preparation for magnetic resonance enterography in patients with Crohn's disease: study protocol for a randomized controlled trial.
Dai M, Zhang T, Li Q, Cui B, et al · · 2019 · cited 15× · PMID 30606236 · DOI 10.1186/s13063-018-3101-x
Bowel preparation after mid-gut tubing enhanced the efficacy and compliance of magnetic resonance enterography in Crohn's disease: a randomized controlled trial.
Wang Y, Dai M, Zheng M, Jin Y, et al · · 2024 · PMID 39346010 · DOI 10.1177/17562848241275337

Verify or expand the search:

Other recruiting trials for Crohn Disease

Currently open trials in the same condition.

NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07310095 — A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) · Phase 4 · recruiting
NCT07364734 — Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease · recruiting
NCT07170462 — Cranberry and Gut Health in Crohn's Disease · EARLY_PHASE1 · recruiting
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease · Phase 2, PHASE3 · recruiting

Other The Second Hospital of Nanjing Medical University trials

Trials by the same sponsor.

NCT07331688 — CMTS0515-auWMT for Radiation Enteritis · Phase 1, PHASE2 · active not recruiting
NCT06839586 — CMTS4520 for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · active not recruiting
NCT06839599 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · not yet recruiting
NCT06844708 — CMTS0929 for Inflammatory Bowel Disease · EARLY_PHASE1 · not yet recruiting
NCT06836427 — CMTS0929 for Clostridioides Difficile Infection · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03541733 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Nanjing Medical University
Last refreshed: 4 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing